Metabolic Syndrome and Breast Cancer Risk: A Case-Cohort Study Nested in a Multicentre Italian Cohort
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Metabolic syndrome (defined as at least three among abdominal obesity, high blood triglycerides, low high-density lipoprotein cholesterol, high blood glucose, and high blood pressure) is emerging as a risk factor for breast cancer; however few studies - most confined to postmenopausal women - have investigated associations between breast cancer risk and metabolic syndrome. The purpose of this study was to examine the association between metabolic syndrome and its components, and risk of breast cancer in postmenopausal and premenopausal women. METHODS: We performed a case-cohort study on 22,494 women recruited in 1993-1998 to four Italian centres (Turin, Varese, Naples, Ragusa) of the European Prospective Investigation into Cancer and Nutrition (EPIC) and followed-up for up to 15 years. A random subcohort of 565 women was obtained and 593 breast cancer cases were diagnosed. Hazard ratios (HR) with 95% confidence intervals (CI), adjusted for potential confounders, were estimated by Prentice-weighted Cox proportional hazards models. RESULTS: Presence of metabolic syndrome was associated with significantly increased breast cancer risk in all women (HR 1.52, 95%CI 1.14-2.02). When the analyses were repeated separately for menopausal status, the association was limited to postmenopausal women (HR 1.80, 95%CI 1.22-2.65) and absent in premenopausal women (HR 0.71, 95%CI 0.43-1.16); P for interaction between metabolic syndrome and menopausal status was 0.001. Of metabolic syndrome components, only high blood glucose was significantly associated with increased breast cancer risk in all women (HR 1.47, 95%CI 1.13-1.91) and postmenopausal women (HR 1.89, 95%CI 1.29-2.77), but not premenopausal women (HR 0.80, 95%CI 0.52-1.22; P interaction=0.004). CONCLUSIONS: These findings support previous data indicating that metabolic syndrome is an important risk factor for breast cancer in postmenopausal women, but not in premenopausal women, and suggest that prevention of metabolic syndrome through lifestyle changes could confer protection against breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Some reports suggest potential harm with the use of these agents.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1719]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Other nutritional supplements, specifically resveratrol, selenium, and vitamin D, have mixed effects on glycemic control and other CV risk factors.1705,1717–1724”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1719]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Food, nutrition, physical activity, and the prevention of cancer: a global perspective
(2008) · Choice Reviews Online · doi:10.5860/choice.45-5024 · Cited by 5,350
Lazcano-Ponce, E. C. (2009) · Salud Pública de México · Cited by 1,669
A case-cohort design for epidemiologic cohort studies and disease prevention trials
PRENTICE, R. L. (1986) · Biometrika · doi:10.1093/biomet/73.1.1 · Cited by 1,439
Estrogen production and action
Nelson, L. R., & Bulun, S. E. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.117432 · Cited by 834
The Insulin-Related Ovarian Regulatory System in Health and Disease
Poretsky, L., Cataldo, N. A., Rosenwaks, Z., & Giudice, L. C. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0374 · Cited by 818
Adiponectin as a Biomarker of the Metabolic Syndrome
Ryo, M., Nakamura, T., Kihara, S., Kumada, M., Shibazaki, S., Takahashi, M., Nagai, M., Matsuzawa, Y., & Funahashi, T. (2004) · Circulation Journal · doi:10.1253/circj.68.975 · Cited by 767
A Prospective Study of Endogenous Estrogens and Breast Cancer in Postmenopausal Women
Toniolo, P. G., Levitz, M., Zeleniuch-Jacquotte, A., Banerjee, S., Koenig, K. L., Shore, R. E., Strax, P., & Pasternack, B. S. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.3.190 · Cited by 620
Kaaks, R., Rinaldi, S., Key, T. J., Berrino, F., Peeters, P. H. M., Biessy, C., Dossus, L., Lukanova, A., Bingham, S., Khaw, K.-T., et al. (2005) · Endocrine-Related Cancer · doi:10.1677/erc.1.01038 · Cited by 527
Self-citationAdipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression
Vona-Davis, L., & Rose, D. P. (2007) · Endocrine-Related Cancer · doi:10.1677/erc-06-0068 · Cited by 496 · cited 1×
“Metabolic syndrome is characterized by high levels of inflammatory cytokines [42] and leptin [43] which can promote breast cancer cell growth through various mechanisms [44, 45], and decreased levels of adiponectin [46], resulting in lack of downregulation of tumour cell proliferation and inhibition of apoptosis [45].”
BackgroundDiabetes, metabolic syndrome, and breast cancer: a review of the current evidence
Xue, F., & Michels, K. B. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.823s · Cited by 353
The Link between the Metabolic Syndrome and Cancer
Braun, S., Bitton-Worms, K., & LeRoith, D. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.1003 · Cited by 326
The IGF system and breast cancer.
Sachdev, D., & Yee, D. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080197 · Cited by 314
Dietary treatment of the metabolic syndrome — the optimal diet
Riccardi, G., & Rivellese, A. A. (2000) · British Journal of Nutrition · doi:10.1017/s0007114500001082 · Cited by 265 · cited 1×
“Metabolic syndrome is a cluster of metabolic abnormalities that occur in persons with impaired insulin sensitivity [3].”
BackgroundAdiposity, type 2 diabetes and the metabolic syndrome in breast cancer
Vona‐Davis, L., Howard‐McNatt, M., & Rose, D. P. (2007) · Obesity Reviews · doi:10.1111/j.1467-789x.2007.00396.x · Cited by 263
Purohit, A., Newman, S. P., & Reed, M. J. (2002) · Breast Cancer Research · doi:10.1186/bcr425 · Cited by 252
Thomas, H. V., Key, T. J., Allen, D. S., Moore, J. W., Dowsett, M., Fentiman, I. S., & Wang, D. Y. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.5.396 · Cited by 246
Diet in the Italian Epic Cohorts: Presentation of Data and Methodological Issues
Pala, V., Sieri, S., Palli, D., Salvini, S., Berrino, F., Bellegotti, M., Frasca, G., Tumino, R., Sacerdote, C., Fiorini, L., et al. (2003) · Tumori Journal · doi:10.1177/030089160308900603 · Cited by 242
Self-citationMetabolic syndrome and cancer risk
Russo, A., Autelitano, M., & Bisanti, L. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2007.11.005 · Cited by 224
Reversal of Relation Between Body Mass and Endogenous Estrogen Concentrations With Menopausal Status
Potischman, N., Swanson, C. A., Siiteri, P., & Hoover, R. N. (1996) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/88.11.756 · Cited by 218
Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: A nested case–control study
Agnoli, C., Berrino, F., Abagnato, C. A., Muti, P., Panico, S., Crosignani, P., & Krogh, V. (2010) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.02.006 · Cited by 195
Self-citationMetabolic Syndrome and Breast Cancer in the Me-Can (Metabolic Syndrome and Cancer) Project
Bjørge, T., Lukanova, A., Jonsson, H., Tretli, S., Ulmer, H., Manjer, J., Stocks, T., Selmer, R., Nagel, G., Almquist, M., et al. (2010) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0230 · Cited by 184
Lawlor, D. A., Smith, G. D., & Ebrahim, S. (2004) · Cancer Causes & Control · doi:10.1023/b:caco.0000024225.14618.a8 · Cited by 182
STANDARDISATION OF OBSERVERS IN BLOOD-PRESSURE MEASUREMENT
Rose, G. (1965) · The Lancet · doi:10.1016/s0140-6736(65)91827-1 · Cited by 170
Adiposity, the Metabolic Syndrome, and Breast Cancer in African-American and White American Women
Rose, D. P., Haffner, S. M., & Baillargeon, J. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0019 · Cited by 166
Metabolic syndrome and the risk of breast cancer in postmenopausal women
Rosato, V., Bosetti, C., Talamini, R., Levi, F., Montella, M., Giacosa, A., Negri, E., & Vecchia, C. L. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr025 · Cited by 166
Insulin regulation of human ovarian androgens
Nestler, J. E. (1997) · Human Reproduction · doi:10.1093/humrep/12.suppl_1.53 · Cited by 162
Diet, serum insulin-like growth factor-I and IGF-binding protein-3 in European women
Norat, T., Dossus, L., Rinaldi, S., Overvad, K., Grønbæk, H., Tjønneland, A. M., Olsen, A., Clavel‐Chapelon, F., Boutron‐Ruault, M., Boeing, H., et al. (2006) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602494 · Cited by 161
Self-citationInoue, M., Noda, M., Kurahashi, N., Iwasaki, M., Sasazuki, S., Iso, H., & Tsugane, S. (2009) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e3283240460 · Cited by 161
Palli, D., Berrino, F., Vineis, P., Tumino, R., Panico, S., Masala, G., Saieva, C., Salvini, S., Cerati, M., Pala, V., et al. (2003) · Tumori Journal · doi:10.1177/030089160308900602 · Cited by 159
Self-citationAromatase and breast cancer susceptibility.
Probst-Hensch, N. M., Ingles, S. A., Diep, A. T., Haile, R. W., Stanczyk, F. Z., Kolonel, L. N., & Henderson, B. E. (1999) · Endocrine-related cancer · doi:10.1677/erc.0.0060165 · Cited by 144
Metabolic syndrome and postmenopausal breast cancer: systematic review and meta-analysis
Esposito, K., Chiodini, P., Capuano, A., Bellastella, G., Maiorino, M. I., Rafaniello, C., & Giugliano, D. (2013) · Menopause · doi:10.1097/gme.0b013e31828ce95d · Cited by 140
Self-citationA Longitudinal Study of the Metabolic Syndrome and Risk of Postmenopausal Breast Cancer
Kabat, G. C., Kim, M., Chlebowski, R. T., Khandekar, J., Ko, M. G., McTiernan, A., Neuhouser, M. L., Parker, D. R., Shikany, J. M., Stefanick, M. L., et al. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0235 · Cited by 120
Bhandari, R., Kelley, G. A., Hartley, T. A., & Rockett, I. R. H. (2014) · International Journal of Breast Cancer · doi:10.1155/2014/189384 · Cited by 118
Capasso, I., Esposito, E., Pentimalli, F., Crispo, A., Montella, M., Grimaldi, M., De Marco, M. R., Cavalcanti, E., D’Aiuto, M., Fucito, A., et al. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.12.13473 · Cited by 108
Prospective study on the role of glucose metabolism in breast cancer occurrence
Sieri, S., Muti, P. C., Agnoli, C., Berrino, F., Pala, V. M., Grioni, S., Abagnato, C. A., Blandino, G., Contiero, P., Schünemann, H. J., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.26071 · Cited by 107
Self-citationMcTernan, P. G., Anwar, A., Eggo, M., Barnett, A. H., Stewart, P., & Kumar, S. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801254 · Cited by 107
Metabolic syndrome and incidence of liver and breast cancers in Japan
Osaki, Y., Taniguchi, S., Tahara, A., Okamoto, M., & Kishimoto, T. (2011) · Cancer Epidemiology · doi:10.1016/j.canep.2011.03.007 · Cited by 95
Al-Delaimy, W. K., Jansen, E. H. J. M., Peeters, P. H. M., van der Laan, J. D., van Noord, P. A. H., Boshuizen, H. C., van der Schouw, Y. T., Jenab, M., Ferrari, P., & Bueno-de-Mesquita, H. B. (2006) · Biomarkers · doi:10.1080/13547500600799748 · Cited by 77
Sex hormone—binding globulin and insulin resistance in African-American women
Sherif, K., Kushner, H., & Falkner, B. E. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90195-0 · Cited by 61 · cited 1×
“In addition, insulin inhibits liver production of sex hormone binding globulin (SHBG), thereby increasing the bioavailability of both estrogens and androgens [41].”
BackgroundRegulation of IGFBP-1 in humans
Brismar, K., Hilding, A., & Lindgren, B. F. (1995) · Progress in Growth Factor Research · doi:10.1016/0955-2235(96)00006-3 · Cited by 49
Cardiometabolic factors and breast cancer risk in U.S. black women
Bosco, J. L. F., Palmer, J. R., Boggs, D. A., Hatch, E. E., & Rosenberg, L. A. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2131-4 · Cited by 46
Diabetes, Overweight and Risk of Postmenopausal Breast Cancer: A Case-Control Study in Uruguay
Ronco, Á. L., Stéfani, E. D., Deneo‐Pellegrini, H., & Quarneti, A. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.1.139 · Cited by 45
Risk Factors for Premenopausal Breast Cancer: A Case-control Study in Uruguay
Ronco, Á. L., Stéfani, E. D., & Deneo‐Pellegrini, H. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.6.2879 · Cited by 43
Breast cancer and metabolic syndrome linked through the plasminogen activator inhibitor‐1 cycle
Beaulieu, L. M., Whitley, B. R., Wiesner, T. F., Réhault‐Godbert, S., Palmieri, D., ELKAHLOUN, A. G., & Church, F. (2007) · BioEssays · doi:10.1002/bies.20640 · Cited by 41
Iacoviello, L., Agnoli, C., Curtis, A. D., Castelnuovo, A. F. D., Giurdanella, M. C., Krogh, V., Mattiello, A., Matullo, G., Sacerdote, C., Tumino, R., et al. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003725 · Cited by 40
Self-citationStrange, K. S., Wilkinson, D. A., & Emerman, J. T. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1019915101457 · Cited by 39
Reeves, K. W., McLaughlin, V., Fredman, L., Ensrud, K. E., & Cauley, J. A. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-0002-2 · Cited by 34
Siemińśka, L., Wojciechowska, C., Fołtyn, W., Kajdaniuk, D., Kos‐Kudła, B., Marek, B., Nasiek, M., Nowak, M., Strzelczyk, J., & Zemczak, A. (2006) · PubMed · Cited by 29
Bradley, L. M., Gierthy, J. F., & Pentecost, B. T. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.10.006 · Cited by 26
Strange, K. S., Wilkinson, D. A., Edin, G., & Emerman, J. T. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000018384.64326.dd · Cited by 23
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Hypertension and breast cancer risk: a systematic review and meta-analysis
Han, H., Guo, W., Shi, W., Yu, Y., Zhang, Y., Ye, X., & He, J. (2017) · Scientific Reports · doi:10.1038/srep44877 · Cited by 231
Effect of Ginger on Inflammatory Diseases
Ballester, P., Cerdá, B., Arcusa, R., Marhuenda, J., Yamedjeu, K., & Zafrilla, P. (2022) · Molecules · doi:10.3390/molecules27217223 · Cited by 214
Seretis, A., Cividini, S., Markozannes, G., Tseretopoulou, X., Lopez, D. S., Ntzani, E. E., & Tsilidis, K. K. (2019) · Scientific Reports · doi:10.1038/s41598-019-45014-4 · Cited by 209
Silveira, E. A., Kliemann, N., Noll, M., Sarrafzadegan, N., & de Oliveira, C. (2021) · Obesity Reviews · doi:10.1111/obr.13088 · Cited by 182
Metadata
- Authors
- Agnoli, C., Grioni, S., Sieri, S., Sacerdote, C., Ricceri, F., Tumino, R., Frasca, G., Pala, V., Mattiello, A., Chiodini, P., Iacoviello, L., De Curtis, A., Panico, S., & Krogh, V.
- Affiliations
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- Italian institute for Genomic Medicine (IT)
- University of Ragusa (IT)
- University of Naples Federico II (IT)
- University of Campania "Luigi Vanvitelli" (IT)
- Istituto Neurologico Mediterraneo (IT)
- Corresponding author
- Sieri, Sabina
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-06-01
- Volume
- 10
- Issue
- 6
- Pages
- e0128891
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4452341
- OpenAlex
- W646343780
- Cited by
- 76
- References
- 52
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 4 · 2023: 2 · 2022: 9 · 2021: 15 · 2020: 5 · 2019: 8 · 2018: 12 · 2017: 6 · 2016: 4 · 2015: 2
- FWCI
- 3.49
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion, cc-by-nc-nd)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- IrInSubria (University of Insubria) (submittedVersion)
- Funders
- Compagnia di San Paolo
- Associazione Italiana per la Ricerca sul Cancro
- Topics
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- breast cancer risk, postmenopausal women, premenopausal women, menopausal status, hyperglycemia, abdominal obesity, dyslipidemia, hypertension, EPIC cohort, risk factors, cancer prevention, Mediterranean diet, breast cancer screening, early detection, early treatment, early mortality
- MeSH terms
- Blood Glucose, Breast Neoplasms, Female, Humans, Hypertension, Italy, Life Style, Prospective Studies, Risk Factors, Case-Control Studies, Premenopause, Postmenopause, Metabolic Syndrome, White People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.